title: Adiponectin is inversely associated with intramyocellular and intrahepatic lipids in obese premenopausal women.
abstract: Adiponectin, an adipokine secreted by adipocytes, exerts beneficial effects on glucose and lipid metabolism and has been found to improve insulin resistance by decreasing triglyceride content in muscle and liver in obese mice. Adiponectin is found in several isoforms and the high-molecular weight (HMW) form has been linked most strongly to the insulin-sensitizing effects. Fat content in skeletal muscle (intramyocellular lipids, IMCL) and liver (intrahepatic lipids, IHL) can be quantified noninvasively using proton magnetic resonance spectroscopy ((1)H-MRS). The purpose of our study was to assess the relationship between HMW adiponectin and measures of glucose homeostasis, IMCL and IHL, and to determine predictors of adiponectin levels. We studied 66 premenopausal women (mean BMI 31.0 ± 6.6 kg/m(2)) who underwent (1)H-MRS of calf muscles and liver for IMCL and IHL, computed tomography (CT) of the abdomen for abdominal fat depots, dual-energy X-ray absorptiometry (DXA) for fat and lean mass assessments, HMW and total adiponectin, fasting lipid profile and an oral glucose tolerance test (homeostasis model assessment of insulin resistance (HOMA(IR)), glucose and insulin area under the curve). There were strong inverse associations between HMW adiponectin and measures of insulin resistance, IMCL and IHL, independent of visceral adipose tissue (VAT) and total body fat. IHL was the strongest predictor of adiponectin and adiponectin was a predictor of HOMA(IR). Our study showed that in premenopausal obese women HMW adiponectin is inversely associated with IMCL and IHL content. This suggests that adiponectin exerts positive effects on insulin sensitivity in obesity by decreasing intracellular triglyceride content in skeletal muscle and liver; it is also possible that our results reflect effects of insulin on adiponectin.
authors.affiliation: Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA. mbredella@partners.org
authors.forename: Miriam A
authors.initials: MA
authors.lastname: Bredella
authors.forename: Martin
authors.initials: M
authors.lastname: Torriani
authors.forename: Reza H
authors.initials: RH
authors.lastname: Ghomi
authors.forename: Bijoy J
authors.initials: BJ
authors.lastname: Thomas
authors.forename: Danielle J
authors.initials: DJ
authors.lastname: Brick
authors.forename: Anu V
authors.initials: AV
authors.lastname: Gerweck
authors.forename: Lindsey M
authors.initials: LM
authors.lastname: Harrington
authors.forename: Karen K
authors.initials: KK
authors.lastname: Miller
mesh_terms: D015502:Absorptiometry, Photon; D052242:Adiponectin / Q000378:metabolism*; D000293:Adolescent; D000328:Adult; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005947:Glucose / Q000378:metabolism*; D006706:Homeostasis; D006801:Humans; D007333:Insulin Resistance; D050152:Intra-Abdominal Fat / Q000000981:diagnostic imaging / Q000378:metabolism*; D050356:Lipid Metabolism; D008099:Liver / Q000000981:diagnostic imaging / Q000378:metabolism*; D009765:Obesity / Q000378:metabolism*; D017697:Premenopause; D014280:Triglycerides / Q000378:metabolism*; D055815:Young Adult
chemical_list: D052242:Adiponectin; D014280:Triglycerides; D005947:Glucose